Acquisition by Ortwein Sara N of 4799 shares of Sanara Medtech subject to Rule 16b-3

SMTI Stock  USD 35.86  0.05  0.14%   
Under 61% of Sanara Medtech's investor base is looking to short. The analysis of overall sentiment of trading Sanara Medtech stock suggests that many investors are alarmed at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
  
Filed transaction by Sanara Medtech Director . Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Sanara insider trading alert for acquisition of common stock by Ortwein Sara N, Director: , on 6th of December 2024. This event was filed by Sanara Medtech with SEC on 2022-07-07. Statement of changes in beneficial ownership - SEC Form 4

Sanara Medtech Fundamental Analysis

We analyze Sanara Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanara Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanara Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Sanara Medtech is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Sanara Medtech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.

Peers

Sanara Medtech Related Equities

KRMDRepro Med   13.70   
0%
100.0%
PDEXPro Dex   3.26   
0%
23.0%
POCIPrecision Optics,   1.74   
0%
12.0%
ATRAptarGroup   0.82   
0%
5.0%
ANGOAngioDynamics   0.77   
0%
5.0%
UTMDUtah Medical   0.47   
3.0%
0%
LMATLeMaitre Vascular   0.71   
5.0%
0%
MMSIMerit Medical   0.73   
5.0%
0%
NVSTEnvista Holdings   1.07   
7.0%
0%
HAEHaemonetics   1.25   
9.0%
0%
MHUAMeihua International   1.69   
12.0%
0%
INFUInfuSystems Holdings   1.86   
13.0%
0%
MLSSMilestone Scientific   2.35   
17.0%
0%
DXRDaxor   5.83   
42.0%
0%

Complementary Tools for Sanara Stock analysis

When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities